He W, Goodkind D, Kowal P, An Aging World. 2015. International Population Reports, P95/16 – 1. Washington, DC: U.S. Government Publishing Office; 2016.
Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: A compass for future health. J Am Coll Cardiol. 2022;80(25):2361–71. https://doi.org/10.1016/j.jacc.2022.11.005.
Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002;106(25):3143–421.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American college of cardiology/american heart association task force on clinical practice guidelines. Circulation. 2018;2019(13925):e1082–143. https://doi.org/10.1161/CIR.0000000000000625.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88. https://doi.org/10.1093/eurheartj/ehz455.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–248. https://doi.org/10.1016/j.jacc.2017.11.006.
Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, et al. 2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Can J Cardiol. 2021;37(8):1129–50. https://doi.org/10.1016/j.cjca.2021.03.016.
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2022;29(1):5–115. https://doi.org/10.1093/eurjpc/zwab154.
Damen JA, Hooft L, Schuit E, Debray TP, Collins GS, Tzoulaki I, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ (Clinical Res ed). 2016;353:i2416. https://doi.org/10.1136/bmj.i2416.
Koller MT, Steyerberg EW, Wolbers M, Stijnen T, Bucher HC, Hunink MG, et al. Validity of the Framingham point scores in the elderly: results from the Rotterdam study. Am Heart J. 2007;154(1):87–93. https://doi.org/10.1016/j.ahj.2007.03.022.
Rodondi N, Locatelli I, Aujesky D, Butler J, Vittinghoff E, Simonsick E, et al. Framingham risk score and alternatives for prediction of coronary heart disease in older adults. PLoS ONE. 2012;7(3):e34287. https://doi.org/10.1371/journal.pone.0034287.
Article PubMed PubMed Central CAS Google Scholar
de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ (Clinical Res ed). 2009;338:a3083. https://doi.org/10.1136/bmj.a3083.
Hamer M, Chida Y, Stamatakis E. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases. Am J Cardiol. 2009;104(4):538–42. https://doi.org/10.1016/j.amjcard.2009.04.020.
Article PubMed CAS Google Scholar
Nanna MG, Peterson ED, Wojdyla D, Navar AM. The accuracy of cardiovascular pooled cohort risk estimates in U.S. Older adults. J Gen Intern Med. 2020;35(6):1701–8. https://doi.org/10.1007/s11606-019-05361-4.
Nguyen QD, Odden MC, Peralta CA, Kim DH. Predicting risk of atherosclerotic cardiovascular disease using pooled cohort equations in older adults with frailty, multimorbidity, and competing risks. J Am Heart Assoc. 2020;9(18):e016003. https://doi.org/10.1161/jaha.119.016003.
Article PubMed PubMed Central Google Scholar
van Bussel EF, Hoevenaar-Blom MP, Poortvliet RKE, Gussekloo J, van Dalen JW, van Gool WA, et al. Predictive value of traditional risk factors for cardiovascular disease in older people: A systematic review. Prev Med. 2020;132:105986. https://doi.org/10.1016/j.ypmed.2020.105986.
Howard G, Banach M, Kissela B, Cushman M, Muntner P, Judd SE, et al. Age-Related differences in the role of risk factors for ischemic stroke. Neurology. 2023;100(14):e1444–53. https://doi.org/10.1212/wnl.0000000000206837.
Article PubMed PubMed Central CAS Google Scholar
Cooney MT, Selmer R, Lindman A, Tverdal A, Menotti A, Thomsen T, et al. Cardiovascular risk Estimation in older persons: SCORE O.P. Eur J Prev Cardiol. 2016;23(10):1093–103. https://doi.org/10.1177/2047487315588390.
Dugani SB, Moorthy MV, Li C, Demler OV, Alsheikh-Ali AA, Ridker PM, et al. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiol. 2021;6(4):437–47. https://doi.org/10.1001/jamacardio.2020.7073.
Ahmadi SF, Streja E, Zahmatkesh G, Streja D, Kashyap M, Moradi H, et al. Reverse epidemiology of traditional cardiovascular risk factors in the geriatric population. J Am Med Dir Assoc. 2015;16(11):933–9. https://doi.org/10.1016/j.jamda.2015.07.014.
Article PubMed PubMed Central Google Scholar
Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695–706.
Article PubMed CAS Google Scholar
Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601–9. https://doi.org/10.1161/circulationaha.115.017719.
Article PubMed PubMed Central Google Scholar
Veronese N, Cereda E, Stubbs B, Solmi M, Luchini C, Manzato E, et al. Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: results from a meta-analysis and exploratory meta-regression analysis. Ageing Res Rev. 2017;35:63–73. https://doi.org/10.1016/j.arr.2017.01.003.
Article PubMed PubMed Central Google Scholar
Neumann JT, Thao LTP, Callander E, Chowdhury E, Williamson JD, Nelson MR, et al. Cardiovascular risk prediction in healthy older people. Geroscience. 2022;44(1):403–13. https://doi.org/10.1007/s11357-021-00486-z.
Article PubMed CAS Google Scholar
O’Neill DE, Forman DE. Cardiovascular care of older adults. BMJ (Clinical research ed). BMJ (Clinical research ed). 2021;374:n1593. https://doi.org/10.1136/bmj.n1593.
Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, et al. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. Eur Heart J. 2019;40(7):621–31. https://doi.org/10.1093/eurheartj/ehy653.
D’Agostino R, Nam B-H. Evaluation of the performance of survival analysis models: discrimination and calibration measures. Handb Stat. 2004;23:1–25.
Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98(9):691–8. https://doi.org/10.1136/heartjnl-2011-301247.
Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98(9):683–90. https://doi.org/10.1136/heartjnl-2011-301246.
Huynh QL, Reid CM, Chowdhury EK, Huq MM, Billah B, Wing LM, et al. Prediction of cardiovascular and all-cause mortality at 10 years in the hypertensive aged population. Am J Hypertens. 2015;28(5):649–56. https://doi.org/10.1093/ajh/hpu213.
Si F, Liu Q, Yu J. A prediction study on the occurrence risk of heart disease in older hypertensive patients based on machine learning. BMC Geriatr. 2025;25(1):27. https://doi.org/10.1186/s12877-025-05679-1.
Comments (0)